Related News
Home » Business » Manufacturing
UK drug maker builds largest factory in Jiangsu
By Ding Yining |
January 4, 2012, Wednesday
|
Online Edition
Online Edition
ASTRAZENECA today started the construction of a US$230 million plant in neighboring Jiangsu Province as it joins other multinational drug companies to ride on the growth of China and other emerging markets.
The new manufacturing facility -- the largest of AstraZeneca, London-based biopharmaceutical company -- is expected to be completed at the end of 2013.
It will produce both drugs developed by AstraZeneca and generic branded pharmaceutical products.
Last November, AstraZeneca took over private-owned Guangdong Beikang Pharmaceutical to diversify its product line for generic drugs.
AstraZeneca also operates a US$134 million manufacturing and supply site in Wuxi New District in Jiangsu Province, which has been in operation since 2001.
The new manufacturing facility -- the largest of AstraZeneca, London-based biopharmaceutical company -- is expected to be completed at the end of 2013.
It will produce both drugs developed by AstraZeneca and generic branded pharmaceutical products.
Last November, AstraZeneca took over private-owned Guangdong Beikang Pharmaceutical to diversify its product line for generic drugs.
AstraZeneca also operates a US$134 million manufacturing and supply site in Wuxi New District in Jiangsu Province, which has been in operation since 2001.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
